Open AccessKRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer
Author(s) -
J. J. Yeh,
E. D. Routh,
T. Rubinas,
J. Peacock,
T. D. Martin,
X. J. Shen,
R. S. Sandler,
H. J. Kim,
T. O. Keku,
C. J. Der
Publication year - 2009
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/2atf-8t95
Subject(s) - kras , colorectal cancer , cancer research , medicine , oncology , mutation , cancer , biology , gene , genetics